MedTrace Logo

Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

NCT04700202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2026-03-23

No results posted yet for this study

Summary

Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP.

Conditions

  • Ventilator-associated Pneumonia
  • Hospital-acquired Pneumonia

Interventions

OTHER

Observational

Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Matthew Crotty, PharmD · Methodist Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2022-12-15
Completion
2022-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04700202 on ClinicalTrials.gov